Antibodies beyond HLA

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 831-832

  Nickerson, P W ^a   Rush, D N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AUTOANTIGEN; HLA ANTIBODY; PERLECAN;

ACUTE VASCULAR REJECTION; CHRONIC GRAFT REJECTION; EDITORIAL; GRAFT FAILURE; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; KIDNEY ALLOGRAFT; PRIORITY JOURNAL; SENSITIZATION; TRANSPLANTATION;

ANIMALS; FEMALE; GRAFT REJECTION; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOGLOBULIN G; MALE; VASCULAR DISEASES;

EID: 84875720766     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12160     Document Type: Editorial

References (9)

1. Zhang Q, Reed EF,. Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol 2010; 22: 682-688.
2. Breimer ME, Rydberg L, Jackson AM, et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 2009; 87: 549-556.
3. Jurcevic S, Ainsworth ME, Madrigal JA, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplant. Transplantation 2001; 71: 886-892. (Pubitemid 32417348)
4. Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T,. Antibodies to K-α 1 tublin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant 2012; 12: 2164-2171.
5. Joosten SA, Sijpkens YWJ, van Ham V, et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005; 5: 383-393. (Pubitemid 40179526)
6. Cardinal H, Dieudé M, Brassard N, et al. Anti-perlecan antibodies are novel accelerators of immune-mediated vascular injury. Am J Transplant 2013; 13: 861-874
7. Amico P, Honger G, Beilman D, et al. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Transplantation 2008; 85: 1557-1563.
8. Joosten SA, Van Dixhoorn MGA, Borrias MC, et al. Antibody response against perlecan and collegen types IV and VI in chronic renal allograft rejection in the rat. Am J Pathol 2002; 160: 1301-1310. (Pubitemid 34411634)
9. Mahesh B, Leong H-S, McCormack A, Sarathchandra P, Holder A, Rose ML,. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol 2007; 170: 1415-1427. (Pubitemid 47339348)